A 45-patient randomized blinded phase II multicenter clinical trial using the gene therapy to treat Parkinson's has recently ended and results are being readied for publication.
最近一个纳入45名帕金森病患者采用基因治疗的研究已经结束并准备将结果公布,该研究是采用随机分组、在第二阶段采用盲法的多中心临床研究。
We now report results from the first phase II clinical trial developed exclusively for SCUC, to our knowledge.
根据我们所知,现在从一项针对SCUC的首次II临床试验得出的结果进行了报道。
应用推荐